Possible impact of tetrahydrobiopterin and sepiapterin on endothelial dysfunction.
Blau
Nenad
N
Thöny
Beat
B
D000429:Alcohol Oxidoreductases / Q000172:deficiency; D000818:Animals; D001708:Biopterins / Q000031:analogs & derivatives* / Q000032:analysis / Q000097:blood / Q000172:deficiency / Q000502:physiology* / Q000652:urine; D001808:Blood Vessels / Q000737:chemistry*; D003327:Coronary Disease / Q000378:metabolism; D004730:Endothelium, Vascular / Q000201:enzymology / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000633:toxicity; D006801:Humans; D006937:Hypercholesterolemia / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D011622:Pterins / Q000378:metabolism* / Q000633:toxicity; D011817:Rabbits; D013045:Species Specificity
D004791:Enzyme Inhibitors; D011622:Pterins; D001708:Biopterins; C016727:sepiapterin; D000429:Alcohol Oxidoreductases; C022630:sepiapterin reductase; D019001:Nitric Oxide Synthase; C003402:sapropterin